Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer.
Radiat Oncol
; 15(1): 278, 2020 Dec 11.
Article
in En
| MEDLINE
| ID: mdl-33308265
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oropharyngeal Neoplasms
/
Radiosurgery
/
Squamous Cell Carcinoma of Head and Neck
Type of study:
Guideline
/
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Radiat Oncol
Journal subject:
NEOPLASIAS
/
RADIOTERAPIA
Year:
2020
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom